Search
A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.
If you think women are the only people who get cancers caused by the human papillomavirus (HPV), think again. These cancers are on the rise in men.
Dr. Mao leads a team of integrative medicine specialists who offer complementary therapies such as massage and acupuncture to patients and caregivers.
A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal residual disease (MRD) responses compared to VRd alone in patients with newly diagnosed, transplant-ineligible multiple myeloma.
Memorial Sloan Kettering Cancer Center (MSK) will further enhance its ability to offer top cancer care to even more patients with the establishment of a freestanding, state-of-the-art outpatient treatment center in Bergen County, New Jersey. Residents from communities across northern New Jersey and southern New York State will have easier access to MSK’s unique expertise when MSK Bergen becomes fully operational in winter 2017.
Could an implantable IUD help detect cancer early, when it is most curable? Scientists at the Sloan Kettering Institute are betting yes.
Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation proudly announce that eight distinguished MSK nurses and one nursing team were honored with the 2024 Robbins Family Award for Nursing Excellence. The awards coincide with National Nurses Week (May 6 – 12).
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Read up on the latest developments in several key areas of cancer research, including genomic mapping, disease modeling through CRISPR, CAR T therapy, and cancer stem cells.
Read why MSK’s medical team is the best in the nation at treating gynecologic cancers.